Cargando…
Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer
AIM: To investigate human epidermal growth factor 2 (HER2) overexpression and validate its prognostic effect in stage II-III gastric cancer. METHODS: We reviewed the data of patients who were diagnosed with gastric cancer between March 2008 and October 2013 at the Yonsei University Medical Center. A...
Autores principales: | Cho, Jang Ho, Lim, Jae Yun, Cho, Jae Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685846/ https://www.ncbi.nlm.nih.gov/pubmed/29151694 http://dx.doi.org/10.3748/wjg.v23.i41.7407 |
Ejemplares similares
-
Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer
por: Suenaga, Yasuhito, et al.
Publicado: (2019) -
No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer
por: Wu, Yun-Zi, et al.
Publicado: (2022) -
Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients
por: Lin, Jian-Xian, et al.
Publicado: (2019) -
PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients
por: Li, A-Jian, et al.
Publicado: (2018) -
Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy
por: Cho, Jang Ho, et al.
Publicado: (2017)